Nivolumab; Ipilimumab – July 2025

Nivolumab (metastatic cancer); Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®; Ipilimumab (metastatic cancer); Injection concentrate for I.V. infusion 50 mg in 10 mL, Injection concentrate for I.V. infusion 200 mg in 40 mL; Yervoy®